These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

612 related articles for article (PubMed ID: 37802125)

  • 21. Function and regulation of cGAS-STING signaling in infectious diseases.
    Du Y; Hu Z; Luo Y; Wang HY; Yu X; Wang RF
    Front Immunol; 2023; 14():1130423. PubMed ID: 36825026
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of cGAS-STING suppresses coxsackievirus replication via interferon-dependent signaling.
    Mohamud Y; Fu C; Fan YM; Zhang YL; Lin JFC; Hwang SW; Wang ZC; Luo H
    Antiviral Res; 2024 Feb; 222():105811. PubMed ID: 38242503
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ectopic expression of cGAS in
    Waanders L; van der Donk LEH; Ates LS; Maaskant J; van Hamme JL; Eldering E; van Bruggen JAC; Rietveld JM; Bitter W; Geijtenbeek TBH; Kuijl CP
    J Immunother Cancer; 2023 Apr; 11(4):. PubMed ID: 37072345
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nanoparticle delivery improves the pharmacokinetic properties of cyclic dinucleotide STING agonists to open a therapeutic window for intravenous administration.
    Wehbe M; Wang-Bishop L; Becker KW; Shae D; Baljon JJ; He X; Christov P; Boyd KL; Balko JM; Wilson JT
    J Control Release; 2021 Feb; 330():1118-1129. PubMed ID: 33189789
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nanodelivery of cGAS-STING activators for tumor immunotherapy.
    Guo J; Huang L
    Trends Pharmacol Sci; 2022 Nov; 43(11):957-972. PubMed ID: 36089410
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Role of cGAS-STING Signalling in Metabolic Diseases: from Signalling Networks to Targeted Intervention.
    Gong J; Gao X; Ge S; Li H; Wang R; Zhao L
    Int J Biol Sci; 2024; 20(1):152-174. PubMed ID: 38164186
    [TBL] [Abstract][Full Text] [Related]  

  • 27. cGAS-STING pathway in cancer biotherapy.
    Wang Y; Luo J; Alu A; Han X; Wei Y; Wei X
    Mol Cancer; 2020 Sep; 19(1):136. PubMed ID: 32887628
    [TBL] [Abstract][Full Text] [Related]  

  • 28. STING pathway as a cancer immunotherapy: Progress and challenges in activating anti-tumor immunity.
    Tabar MMM; Fathi M; Kazemi F; Bazregari G; Ghasemian A
    Mol Biol Rep; 2024 Apr; 51(1):487. PubMed ID: 38578532
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DNA sensing in cancer: Pro-tumour and anti-tumour functions of cGAS-STING signalling.
    Wheeler OPG; Unterholzner L
    Essays Biochem; 2023 Sep; 67(6):905-918. PubMed ID: 37534795
    [TBL] [Abstract][Full Text] [Related]  

  • 30. cGAS/STING cross-talks with cell cycle and potentiates cancer immunotherapy.
    Long ZJ; Wang JD; Xu JQ; Lei XX; Liu Q
    Mol Ther; 2022 Mar; 30(3):1006-1017. PubMed ID: 35121107
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beyond DNA sensing: expanding the role of cGAS/STING in immunity and diseases.
    Seok JK; Kim M; Kang HC; Cho YY; Lee HS; Lee JY
    Arch Pharm Res; 2023 Jun; 46(6):500-534. PubMed ID: 37354378
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DNA damage-triggered activation of cGAS-STING pathway induces apoptosis in human keratinocyte HaCaT cells.
    Li C; Liu W; Wang F; Hayashi T; Mizuno K; Hattori S; Fujisaki H; Ikejima T
    Mol Immunol; 2021 Mar; 131():180-190. PubMed ID: 33423764
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nanoparticle-Mediated STING Activation for Cancer Immunotherapy.
    Li Y; Li X; Yi J; Cao Y; Qin Z; Zhong Z; Yang W
    Adv Healthc Mater; 2023 Jul; 12(19):e2300260. PubMed ID: 36905358
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Engineering cGAS-agonistic oligonucleotides as therapeutics and vaccine adjuvants for cancer immunotherapy.
    Zhou S; Su T; Cheng F; Cole J; Liu X; Zhang B; Alam S; Liu J; Zhu G
    bioRxiv; 2023 Jul; ():. PubMed ID: 37502970
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting Lymph Nodes for Systemic Immunosuppression Using Cell-Free-DNA-Scavenging And cGAS-Inhibiting Nanomedicine-In-Hydrogel for Rheumatoid Arthritis Immunotherapy.
    Cheng F; Su T; Liu Y; Zhou S; Qi J; Guo W; Zhu G
    Adv Sci (Weinh); 2023 Sep; 10(26):e2302575. PubMed ID: 37435620
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Compound Danshen Dripping Pill effectively alleviates cGAS-STING-triggered diseases by disrupting STING-TBK1 interaction.
    Shi W; Xu G; Gao Y; Yang H; Liu T; Zhao J; Li H; Wei Z; Hou X; Chen Y; Wen J; Li C; Zhao J; Zhang P; Wang Z; Xiao X; Bai Z
    Phytomedicine; 2024 Jun; 128():155404. PubMed ID: 38507852
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Significance of the cGAS-STING Pathway in Health and Disease.
    Zhou J; Zhuang Z; Li J; Feng Z
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686127
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanism and therapeutic potential of targeting cGAS-STING signaling in neurological disorders.
    Huang Y; Liu B; Sinha SC; Amin S; Gan L
    Mol Neurodegener; 2023 Nov; 18(1):79. PubMed ID: 37941028
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of the cGAS-STING pathway in systemic and organ-specific diseases.
    Skopelja-Gardner S; An J; Elkon KB
    Nat Rev Nephrol; 2022 Sep; 18(9):558-572. PubMed ID: 35732833
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The cGas-Sting Signaling Pathway Is Required for the Innate Immune Response Against Ectromelia Virus.
    Cheng WY; He XB; Jia HJ; Chen GH; Jin QW; Long ZL; Jing ZZ
    Front Immunol; 2018; 9():1297. PubMed ID: 29963044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.